Since CRC patients with high Mucin-1 expression in tumor tissue have a higher risk of metastasis, the level of Mucin-1 expression is important in guiding treatment plans, so determining Mucin-1 expression in CRC by immunohistochemical methods may be important for determining treatment strategies in a clinical setting [17,18]. This evidence concerns the gene MUC1 and neoplasm.